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S.1 Preparation of MnO nanoparticles (MONPs)
The 25 nm MONPs were synthesized by following a previously published protocol.
1-2
Mn-oleate (1.24 g) was added into 10 mL of 1-octadecene (90 %, Aldrich) to yield a transparent red solution. The mixture was heated to 160 °C and remained at this temperature under Ar protection for 1 h to remove water and oxygen and then heated to 300 °C with vigorous stirring.
The reaction system was maintained at 300 °C for 1 h and then cooled down to room temperature. 20 mL of hexane was added into the product, followed by the addition of 80 mL acetone to precipitate the nanoparticles. The precipitate was collected by centrifugation and washed for 2 more times to remove excess surfactant and solvent.
To synthesize Mn-oleate complex, 1.98 g manganese chloride tetrahydrate (MnCl 2 •4H 2 O, 10 mmol, Sigma-Aldrich, 98%) and 6.09 g sodium oleate (20 mmol, TCI, 95%) were added to a mixture composed of 10 mL of ethanol, 40 mL of distilled water and 50 mL of n-hexane. The resulting mixture was heated to 70 °C and stirred overnight. The final product was washed several times by using water, and then heated to 50 °C to remove hexane.
S.2 Preparation of Alkyl-PEI2k-MnO/siRNA complexes
Alkyl-PEI2k was prepared by following our previously reported protocol. [3] [4] [5] Briefly, Alkyl-PEI2k-MnOs were prepared by following the protocol below. Typically, 5 mg MnO nanoparticles (MONPs) in hexane were dried under argon and redispersed in 1 mL chloroform together with 10 mg Alkyl-PEI2k. Then, the mixed solution was slowly added into 1 mL water with sonication. The mixture was under shaking for overnight and the remaining chloroform was removed by rotary evaporation, which was then dialysed for 48 h to remove the free Alkyl-PEI2k.
Alkyl-PEI2k-MnO/siRNA complexes at different N/P ratios (N/P ratios of 1:1, 2:1, 5:1, 10:1 and 20:1) were prepared by adding appropriate amount of Alkyl-PEI2k-MnOs into firefly luciferase siRNA (Ambion) (6 pmol) in PBS under agitation. The resulting mixture was incubated at room temperature for 20 min.
S.3 Agarose Gel Electrophoresis of Alkyl-PEI2k-MnO/siRNA Complexes
Alkyl-PEI2k-MnO/siRNA complexes were analyzed by 2% agarose gel electrophoresis and heparin decomplexation assay. 6 The gels were prepared with 2% agarose in Tris-acetate-EDTA buffer containing 0.5 μg/mL ethidium bromide. Gel electrophoresis was carried out at 100 V for 15 min and the gel was subsequently imaged using a LAS-3000 gel documentation system (Fujifilm Life Science, Japan). For heparin decomplexation assay, Alkyl-PEI2k-MnOs were first complexed with siRNA (N/P ratio = 20:1) at room temperature for 20 min. Then, various amounts of heparin (heparin/siRNA weight ratio 0, 1, 5, 20 and 100) were added and the mixtures were further incubated for 15 min. The samples were loaded onto a 2 % agarose gel again and subjected to electrophoresis as described above.
S.4 Cell Culture
The 4T1 breast cancer cells were purchased from the American Type Culture Collection 
S.7 MRI Study of Transfected Cells
Fluc-4T1 cells were conducted with Alkyl-PEI2k-MnO/siRNA complexes at a N/P ratio of 10.
After transfection for 3 h, cells were washed three times with PBS, harvested, and processed for MR imaging as described below. After carefully counted, cells (10 6 , 2×10 
